Norwegian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Side 1 fra 34 resultater
Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of a dihydrochalcone-rich phenolic fraction in the cosmetic treatment of mammals in order to limit the weight, to improve the aesthetic appearance of the body and to treat certain non-pathological forms of
Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of a dihydrochalcone-rich phenolic fraction in the cosmetic treatment of mammals in order to limit the weight, to improve the aesthetic appearance of the body and to treat certain non-pathological forms of
Allium sativum bulb absolutes and therapeutic or cosmetic uses
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The invention concerns Allium sativum (garlic) bulb extracts and uses thereof. Said compositions can be advantageously and more particularly used in the pharmaceutical and cosmetics industry. The invention thus also concerns therapeutic compositions (medicaments), particularly for the treatment of
Oral compositions for the treatment of non-diabetic obese mammals, including humans
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
This application is a 371 of PCT/ES02/00231, filed on May 16, 2002, which claims benefit of priority to ES 200101200, filed on May 16, 2001.
The invention refers to the use of oral compositions for the treatment of non-diabetic mammals, including humans suffering from obesity and/or overweight. The
Medicinal herbal extract having anti-obesity effect
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
The present invention relates to an obesity preventing or therapeutic agent including an extract of lysimachiae foenum-graeci herba as an active ingredient, and more particularly to a raw material, a functional food, cosmetic, and a crude drug for preventing/treating obesity, which
RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
CROSS-REFERENCE TO RELATED APPLICATIONS
Also, each of the following copending applications are assigned to the assignee hereof. Application Ser. No. 08/429,492, now U.S. Pat. No. 5,705,167 and Ser. No. 08/429,045, now U.S. Pat. No. 5,574,036, and applications Ser. No. 08/356,913, now U.S. Pat. No.
Antiadipose topical treatment composition based on garlic bulbs extracts, and cosmetic and therapeutic uses
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The invention relates to an antiadipose topical treatment composition and to the uses of this composition and/or of garlic bulbs extracts cosmetically for preventively or curatively treating cellulite and localized dermal excess adipose, or therapeutically for treating obesity.
More than 90% of
Female menopause alleviation use of composition containing composite extract of red clover and pomegranate as active ingredient
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
The present disclosure relates to a natural composition showing an outstanding effect in a variety of applications, and more particularly, to a natural plant composite extract showing an outstanding effect in relieving menopausal symptoms.
The present application claims priority to
Brown fat cell compositions and methods
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
FIELD OF THE INVENTION
This invention relates to the field of cell culture and more specifically to the culture and use of stem cells.
BACKGROUND
Brown fat is one of two types of adipose tissue found in the human body. During embryogenesis, brown fat is derived from the differentiation of the
Brown fat cell compositions and methods
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
BACKGROUND
Brown fat is one of two types of adipose tissue found in the human body. During embryogenesis, brown fat is derived from the differentiation of the mesoderm. Brown fat is involved in development and homeostasis by providing metabolic tissue capable of providing heat. Brown fat helps
Viscous compositions containing carbon dioxide
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
TECHNICAL FIELD
Thee present invention relates to a carbon dioxide-containing viscous composition which is capable of treating or ameliorating itching accompanying mucocutaneous diseases or mucocutaneous disorders such as athlete's foot, insect bite, atopic dermatitis, nummular eczema, xeroderma,
Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives and uses thereof, particularly in the fields of human and veterinary health. The compounds according to the invention have pharmacological antioxidant properties and PPAR.alpha. and PPAR.gamma.
Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
This application is the US national phase of international application PCT/FR2003/002128 filed 8 Jul. 2003 which designated the U.S. and claims benefit of FR 02/08570, dated 8 Jul. 2002, the entire content of which is hereby incorporated by reference.
The invention concerns compositions comprising
Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
The invention concerns compositions comprising substituted 1,3-diphenylprop-2-en-1-one derivatives and uses thereof, particularly in the fields of human and veterinary health. The compounds according to the invention have pharmacological antioxidant properties and PPAR.alpha. and PPAR.gamma.
Fatty acid derivatives; preparation and uses thereof
Bare registrerte brukere kan oversette artikler
Logg inn Registrer deg
This application is the U.S. national phase of international application PCT/FR02/02831, filed in French on 08 Aug. 2002, which designated the U.S. PCT/FR02/02831 claims priority to FR Application No. 01 10645, filed 09 Aug. 2001. The entire contents of these applications are incorporated herein by
Den mest komplette databasen med medisinske urter støttet av vitenskap
- Fungerer på 55 språk
- Urtekurer støttet av vitenskap
- Urtegjenkjenning etter bilde
- Interaktivt GPS-kart - merk urter på stedet (kommer snart)
- Les vitenskapelige publikasjoner relatert til søket ditt
- Søk medisinske urter etter deres effekter
- Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot.
* All informasjon er basert på publisert vitenskapelig forskning
